| Sonia Prem, | |
|
2400 Veterans Blvd., 215, Kenner, LA 70065 | |
| (504) 405-5280 | |
| (504) 405-5434 |
| Full Name | Sonia Prem |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 2400 Veterans Blvd., Kenner, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295194264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sonia Prem, 2400 Veterans Blvd., 215, Kenner, LA 70065 Ph: (504) 405-5280 | Sonia Prem, 2400 Veterans Blvd., 215, Kenner, LA 70065 Ph: (504) 405-5280 |
News Archive
A joint study carried out by The University of Nottingham and the multinational food company Unilever has found for the first time that fat in food can reduce activity in several areas of the brain which are responsible for processing taste, aroma and reward.
Dr. Mikhail V. Blagosklonny, M.D., Ph.D., Editor-in-Chief of Oncotarget, and Professor, at Roswell Park Cancer Institute, published "The goal of geroscience is life extension" which was selected as the Featured Cover Paper for Volume 12 Issue 3 and reported that although numerous drugs seemingly extend healthspan in mice, only a few extend lifespan in mice and only one does it consistently.
Children who cannot eat on their own because of intestinal failure must rely on parenteral nutrition (PN), an intravenous method of feeding.
CombiMatrix Corporation announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company's diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing tests, expanding the test menu, increasing the number of customers and partners, and improving reimbursement for its testing services.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.
› Verified 8 days ago
Henry Augustus Lutterodt, Counselor Medicare: Not Enrolled in Medicare Practice Location: 912 Sessions Ln, Kenner, LA 70065 Phone: 336-457-4153 | |
Jose Chacon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2600 Kingston St, Unit C, Kenner, LA 70062 Phone: 504-315-0363 | |
Cedrick Doucet, MSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 2400 Veterans Memorial Blvd, Suite 215, Kenner, LA 70062 Phone: 504-405-5280 Fax: 504-405-5434 | |
Kenmeisha Norlondra Ezidore, Counselor Medicare: Not Enrolled in Medicare Practice Location: 522 Farrar Ave, Kenner, LA 70062 Phone: 504-579-3746 | |
Mrs. Jeannette Marie Zapata, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2616 Tupelo St, Kenner, LA 70062 Phone: 504-338-2530 | |
Cassandra Guillaume, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1000 Clay St, Kenner, LA 70062 Phone: 504-278-4006 Fax: 504-278-4007 | |
Jonathan English, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3701 Tulane Dr, Kenner, LA 70065 Phone: 504-952-5811 |